Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2009
06/25/2009WO2009077741A2 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents
06/25/2009WO2009077736A2 A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist
06/25/2009WO2009077728A1 Indoles and their therapeutic use
06/25/2009WO2009077693A2 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent
06/25/2009WO2009077680A1 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
06/25/2009WO2009077677A2 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
06/25/2009WO2009077608A1 2 -aminopyrimidine derivatives as histamine h4 antagonists
06/25/2009WO2009077585A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/25/2009WO2009077584A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
06/25/2009WO2009077574A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
06/25/2009WO2009077573A2 Suspension comprising non-micronized ezetimibe micro-particles
06/25/2009WO2009077559A2 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators
06/25/2009WO2009077551A1 Process for preparing risperidone
06/25/2009WO2009077533A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists
06/25/2009WO2009077527A1 Anthelmintic agents and their use
06/25/2009WO2009077500A2 Azolylmethyloxiranes, use thereof and agents containing the same
06/25/2009WO2009077497A2 Azolyl methyl oxiranes, the use thereof, and agents containing them
06/25/2009WO2009077485A2 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents
06/25/2009WO2009077484A2 A cyano piperidinyl-phenil-oxazolidinone and use thereof.
06/25/2009WO2009077471A2 Azolylmethyloxiranes, use thereof and agents containing the same
06/25/2009WO2009077448A1 Kinesin inhibitors as cancer therapeutics
06/25/2009WO2009077443A2 Azolylmethyloxiranes, use thereof and agents containing the same
06/25/2009WO2009077387A1 2-fluoro-4-[(3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl)amino]benzoate derivatives; compositions containing same; cosmetic uses
06/25/2009WO2009077385A1 Leukotriene b4 inhibitors
06/25/2009WO2009077371A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
06/25/2009WO2009077367A1 Novel pyrazole-substituted arylamides
06/25/2009WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists
06/25/2009WO2009077365A1 Novel imidazole-substituted arylamides
06/25/2009WO2009077362A1 Isothiazolidine 1,1-dioxide and tetrahydro-2h-1,2-thiazine 1,1-dioxide derivatives as p2x7 modulators
06/25/2009WO2009077352A1 Prevention of opportunistic infections in immune-compromised subjects
06/25/2009WO2009077345A1 Transcutaneous pharmaceutical compositions containing a steroid hormone
06/25/2009WO2009077334A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives
06/25/2009WO2009077187A2 Compositon for enhancing immunity
06/25/2009WO2009077186A1 Nonsteroidal progesterone receptor modulators
06/25/2009WO2009077162A1 Novel use of amidine derivates
06/25/2009WO2009077147A2 Pharmaceutical compositions
06/25/2009WO2009077068A1 Ester derivatives as phosphodiesterase inhibitors
06/25/2009WO2009076983A2 Improved pharmaceutical composition containing non-ergoline dopamine agonist and method for the preparation thereof
06/25/2009WO2009076965A1 Sertindole for the treatment of mania-related disorders
06/25/2009WO2009076962A1 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter
06/25/2009WO2009076961A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
06/25/2009WO2009076873A1 A biocompatible denatured starch sponge material
06/25/2009WO2009076869A1 Salvianolic acid of high purity, preparation method and use thereof
06/25/2009WO2009076775A1 Immune response modulation and uses thereof
06/25/2009WO2009076764A1 Misuse preventative, controlled release formulation
06/25/2009WO2009076761A1 Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
06/25/2009WO2009076754A1 Single layered controlled release therapeutic system
06/25/2009WO2009076747A1 Viral polymerase inhibitors
06/25/2009WO2009076742A1 Effervescent dietary composition for enhancing delivery of dietary ingredients
06/25/2009WO2009076741A1 Creatinol-fatty acid esters
06/25/2009WO2009076693A1 Octahydroquinoli zines for antidiabetic treatment
06/25/2009WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
06/25/2009WO2009061152A3 Composition for prevention and treatment of pain containing curcumin or pharmaceutically acceptable salt thereof as an active ingredient
06/25/2009WO2009060292A3 Smac mimetic compounds as apoptosis inducers
06/25/2009WO2009060122A3 Use of oligonucleotides with modified bases as antiviral agents
06/25/2009WO2009060064A3 Pharmaceutical formulations for the oral administration of ppi
06/25/2009WO2009058729A3 Thiazole carboxamide derivatives and their to treat cancer
06/25/2009WO2009056754A9 Use of econazole or salts thereof for treating acne
06/25/2009WO2009056692A3 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
06/25/2009WO2009053840A3 Solid forms of (±)-o-desmethylvenlafaxine salts
06/25/2009WO2009053683A3 Treatment of inflammatory diseases
06/25/2009WO2009053038A3 Combination therapy of a type ii anti-cd20 antibody with a proteasome inhibitor
06/25/2009WO2009052200A3 Human adam-10 inhibitors
06/25/2009WO2009051806A3 Modulation of nerve pain activity by resiniferatoxin and uses thereof
06/25/2009WO2009050726A3 Compositions and methods for improved delivery of bupropion
06/25/2009WO2009049961A3 New no-donor aspirin derivatives
06/25/2009WO2009049813A3 Process for producing a monophasic pharmaceutical product for limiting/reducing the risk of deep vein thrombosis united with oral contraception
06/25/2009WO2009048541A3 Compounds and methods for use in treating neoplasia and cancer
06/25/2009WO2009046842A3 Thiazol derivatives for treating cancer
06/25/2009WO2009046123A3 Nlrr-1 antagonists and uses thereof
06/25/2009WO2009043577A3 Contraceptive 19-nor progesterones
06/25/2009WO2009042668A3 Urea-containing peptides as inhibitors of viral replication
06/25/2009WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors
06/25/2009WO2009040730A3 Pyrrolidines and piperidines as orexin receptor antagonists
06/25/2009WO2009040445A3 Arabinoxylo-oligosaccharides useful against gastrointestinal infections
06/25/2009WO2009040420A3 Use of a monoterpene to increase tissue repair
06/25/2009WO2009034547A3 New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof
06/25/2009WO2009033039A9 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
06/25/2009WO2009032270A3 A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
06/25/2009WO2009032267A3 Contact lens based bioactive agent delivery system
06/25/2009WO2009027994A4 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL
06/25/2009WO2009023471A3 Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation
06/25/2009WO2009020561A3 Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extract thereof in combination with a steroid
06/25/2009WO2009018132A9 Methods and systems for attenuating the tolerance response to a drug
06/25/2009WO2009017837A9 Sublingual fentanyl spray
06/25/2009WO2009013480A3 Antibacterial combination therapy
06/25/2009WO2009009122A3 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
06/25/2009WO2009007856A3 Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium
06/25/2009WO2008145840A3 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
06/25/2009WO2008131149A3 Crystal forms of saxagliptin and processes for preparing same
06/25/2009WO2008130619A3 A composition comprising an inhibitor of pde4 and/or pde7
06/25/2009WO2008129023A3 Oligonucleotide compositions for the treatment of alzheimer's disease
06/25/2009WO2008113450A3 Use of chroman-4-on-derivatives
06/25/2009WO2008110872A3 Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
06/25/2009WO2008110374A3 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same
06/25/2009WO2008103431A3 Dnai - liposomes
06/25/2009WO2008098396A3 Oxazolidinones and their use as hypocholesterolemic agents
06/25/2009WO2008089087A3 Tablet-in-tablet compositions
06/25/2009WO2008076278A4 Methods of cancer treatment with igf1r inhibitors
06/25/2009WO2008068173A9 4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators
1 ... 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 ... 7860